Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2015 2
2017 1
2019 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
The Carbapenemase-Producing Klebsiella pneumoniae Population Is Distinct and More Clonal than the Carbapenem-Susceptible Population.
Esteban-Cantos A, Aracil B, Bautista V, Ortega A, Lara N, Saez D, Fernández-Romero S, Pérez-Vázquez M, Navarro F, Grundmann H, Campos J, Oteo J; EuSCAPE-Spain Network. Esteban-Cantos A, et al. Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02520-16. doi: 10.1128/AAC.02520-16. Print 2017 Apr. Antimicrob Agents Chemother. 2017. PMID: 28137818 Free PMC article.
Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipients.
Ruiz-Camps I, Len O, de la Cámara R, Gurguí M, Martino R, Jarque I, Barrenetxea C, Díaz de Heredia C, Batlle M, Rovira M, de la Torre J, Torres A, Aguilar M, Espigado I, Martín-Dávila P, Bou G, Borrell N, Aguado JM, Pahissa A; Spanish Network for Research on Infection in Transplantation (RESITRA/REIPI). Spain. Ruiz-Camps I, et al. Antivir Ther. 2011;16(7):951-7. doi: 10.3851/IMP1858. Antivir Ther. 2011. PMID: 22024510
METHODS: This was a 2-year prospective, comparative cohort study in which 237 episodes of pre-emptive therapy for active CMV infection were collected in 166 allogeneic HSCT recipients out of 717 included in the Spanish Network for Research on Infection in Transplantation ( …
METHODS: This was a 2-year prospective, comparative cohort study in which 237 episodes of pre-emptive therapy for active CMV infection were …
Universal prophylaxis with fluconazole for the prevention of early invasive fungal infection in low-risk liver transplant recipients.
San-Juan R, Aguado JM, Lumbreras C, Fortun J, Len O, Muñoz P, Montejo M, Moreno A, Cordero E, Blanes M, Ramos A, de la Torre-Cisneros J, Lopez-Medrano F, Carratala J, Moreno E; RESITRA-REIPI Network, Spain. San-Juan R, et al. Transplantation. 2011 Aug 15;92(3):346-50. doi: 10.1097/TP.0b013e3182247bb4. Transplantation. 2011. PMID: 21709604
BACKGROUND: Although antifungal prophylaxis in high-risk liver transplant recipients (LTR) seems to be clearly justified, the efficacy of universal prophylaxis (UP) including low-risk patients is controversial. METHODS: From the study cohort RESITRA-REIPI, which prospectiv …
BACKGROUND: Although antifungal prophylaxis in high-risk liver transplant recipients (LTR) seems to be clearly justified, the efficacy of un …
Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial.
Shaw E, Miró JM, Puig-Asensio M, Pigrau C, Barcenilla F, Murillas J, Garcia-Pardo G, Espejo E, Padilla B, Garcia-Reyne A, Pasquau J, Rodriguez-Baño J, López-Contreras J, Montero M, de la Calle C, Pintado V, Calbo E, Gasch O, Montejo M, Salavert M, Garcia-Pais MJ, Carratalà J, Pujol M; Spanish Network for Research in Infectious Diseases (REIPI RD12/0015); Instituto de Salud Carlos III, Madrid, Spain; GEIH (Hospital Infection Study Group). Shaw E, et al. BMJ Open. 2015 Mar 11;5(3):e006723. doi: 10.1136/bmjopen-2014-006723. BMJ Open. 2015. PMID: 25762232 Free PMC article. Clinical Trial.
Effect of delaying prophylaxis against CMV in D+/R- solid organ transplant recipients in the development of CMV-specific cellular immunity and occurrence of late CMV disease.
San-Juan R, Navarro D, García-Reyne A, Montejo M, Muñoz P, Carratala J, Len O, Fortun J, Muñoz-Cobo B, Gimenez E, Eworo A, Sabe N, Meije Y, Martin-Davila P, Andres A, Delgado J, Jimenez C, Amat P, Fernández-Ruiz M, López-Medrano F, Lumbreras C, Aguado JM; REIPI Network, Spain; GESITRA Study Group from the SEIMC. San-Juan R, et al. J Infect. 2015 Nov;71(5):561-70. doi: 10.1016/j.jinf.2015.06.013. Epub 2015 Jul 14. J Infect. 2015. PMID: 26183297
Prognosis of urinary tract infection caused by KPC-producing Klebsiella pneumoniae: The impact of inappropriate empirical treatment.
Rodriguez-Gómez J, Pérez-Nadales E, Gutiérrez-Gutiérrez B, Machuca I, Martinez-Martinez L, Rivera F, Cano A, Castón JJ, Robles JC, de la Fuente C, Rodríguez-López F, Rodriguez-Baño J, Torre-Cisneros J; Spanish Network for Research in Infectious Diseases (REIPI), Instituto de Salud Carlos III, Madrid, Spain. Rodriguez-Gómez J, et al. J Infect. 2019 Sep;79(3):245-252. doi: 10.1016/j.jinf.2019.06.014. Epub 2019 Jul 2. J Infect. 2019. PMID: 31276705